Cagrilintide GLP 1 C Peptide Research Grade Lyophilized Powder BleauGenics Beyond GLP 1: the next wave of weight loss medication innovation The Pharmaceutical Journal Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit What is the pipeline for future medications for obesity? International Journal of Obesity Targeting GLP 1, GIP & GCG in Obesity and Type 2 Diabetes Research Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link